Tag Archives: aspirin

Risk of bleeding with daily aspirin may offset benefit in low-risk patients

Chronic use of low-dose aspirin, defined as 300 mg/day or less, is associated with an increased risk of major gastrointestinal (GI) or cerebral bleeding, a recent review of administrative data found. Patients with diabetes also were found to have a high rate of bleeding, irrespective of aspirin use. Key Point:… 

Read more »
Posted in Cardiovascular, Diabetes, Non-Communicable Disease, Non-Communicable Disease Featured 2, Primary Care | Also tagged , , , , , , , , , , , , , , , , , , | Volume: | 2 Responses

NSAID use may be associated with decreased risk of skin cancer

A meta-analysis has found that the use of NSAIDs—including ibuprofen, aspirin, and naproxen—was associated with a decreased risk of skin cancer. “This study is interesting, but a concern of long-term use of NSAIDs includes renal and gastric complications.” -Saumen Chaudhuri, MD, medical officer, State Public Health Services, South Dinajpur Hospital,… 

Read more »
Posted in Dermatology, Oncology, Pharmacology, Primary Care | Also tagged , , , , , , , , , , | Volume: | Leave a comment

Use of beta-blockers and aspirin in cancer patients with acute myocardial infarction prolongs survival

In patients with cancer who had an acute myocardial infarction (AMI) the use of beta-blockers and aspirin were each associated with improved survival. The population was primarily comprised of patients with non-ST-segment elevation myocardial infarction (NSTEMI). This was the main finding of a recent observational study published in Clinical Cardiology…. 

Read more »
Posted in Cardiovascular Disease, Oncology, Pharmacology | Also tagged , , , , , , | Volume: | Leave a comment

Prolonged venous thromboembolism prophylaxis with aspirin appears safe and effective

While once thought to be rare, recent data published by Lee and colleagues suggest the incidence of venous thromboembolism (eg, deep vein thrombosis or pulmonary embolism) is on the rise in India, accounting for about 17.5 per 10,000 hospital admissions. Unfortunately, approximately 20% of patients experiencing an unprovoked venous thromboembolism… 

Read more »
Posted in Cardiovascular Disease, Pharmacology | Also tagged , , , , , , , , | Volume: | Leave a comment

Meta-analyses: Aspirin’s utility in chronic kidney disease isn’t clear

An increase in the risk of bleeding may nullify the benefits of antiplatelet therapy in patients with chronic kidney disease (CKD), according to a pair of meta-analyses. The evidence from clinical trials included in the meta-analyses is of low quality, the authors reported, with numerous limitations. “Bleeding hazards and lack… 

Read more »
Posted in Cardiovascular Disease, Diabetes, Nephrology, Pharmacology, Primary Care | Also tagged , , , , , , , | Volume: | Leave a comment

Regular aspirin use may reduce risk of cancer metastasis

Daily aspirin may prevent distant cancer metastasis, according to a recent analysis. Researchers from the United Kingdom examined 5 large, randomized trials (17,285 participants) of daily aspirin (≥75 mg daily) vs control for the prevention of vascular events to assess the effect of aspirin on the frequency of distant metastasis… 

Read more »
Posted in Non-Communicable Disease, Oncology, Pharmacology, Primary Care | Also tagged , , , , , , | Volume: | Leave a comment

Long-term therapeutic aspirin could offer protection against cancer

Long-term aspirin use may offer protection against cancer, a recent study has found. In analyzing data from 6 trials of daily low-dose aspirin in the primary prevention of vascular events (35,535 participants) and 51 clinical trials (including 34 randomized trials) of daily aspirin vs controls for the prevention of vascular… 

Read more »
Posted in Oncology | Also tagged , , , , , | Volume: | Leave a comment